Currently approved in Australia

COVID-19

Corona viruses are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome(MERS-CoV) and Severe Acute Respiratory Syndrome(SARS-CoV). World Health Organization(WHO) announced that the outbreak of corona virus disease(COVID-19) was first reported from Wuhan, China, on 31 December 2019.

Kodatef

(tafenoquine)

Kodatef is approved for malaria prevention (prophylaxis) when travelling to areas where malaria is present. For information regarding Kodatef, including the Therapeutic Goods Administration (TGA) approved Consumer Medical Information and Product Information (for health professionals only), please click the button below.

‚Äč

Biocelect Logo_Colour.png
  • LinkedIn Social Icon

Copyright 2019 Biocelect 

Suite 405, Level 4, 51 Rawson Street Epping, NSW Australia 2121

Level 5, Wynn Williams House, 47 Hereford Street, Christchurch 8013, New Zealand